Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-20

FDA Approved: AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for amiloride hydrochloride and hydrochlorothiazide from Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (amiloride hydrochloride and hydrochlorothiazide)

Snippet

SUPPL AP for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE)